Biosino Suzhou Medical Instrument Co., Ltd announced that it will raise CNY 20 million in a round of funding on August 17, 2023. The transaction included participation from new investors, Biosino Bio-Technology and Science Incorporation, Beijing Chenyimeng, China Technology Industry Group Limited, Hefei Tashi for CNY 5 million, Hefei Xiangpeng for CNY 5 million. The transaction has been approved by shareholder of the company.
Biosino Bio-Technology and Science Incorporation
Equities
8247
CNE100000288
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 HKD | 0.00% | -2.17% | +12.50% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
0.9 HKD | 0.00% | -2.17% | 16.66M | ||
0.08 HKD | 0.00% | 0.00% | 4.72M | ||
1st Jan change | Capi. | |
---|---|---|
+12.50% | 16.66M | |
-1.24% | 12.58B | |
+0.13% | 8.51B | |
-1.01% | 5.29B | |
+20.18% | 5.16B | |
-0.74% | 4.55B | |
-54.68% | 3.04B | |
+24.56% | 3B | |
+25.13% | 2.17B | |
-1.86% | 1.92B |
- Stock Market
- Equities
- 8247 Stock
- News Biosino Bio-Technology and Science Incorporation
- Biosino Suzhou Medical Instrument Co., Ltd announced that it expects to receive CNY 20 million in funding from Biosino Bio-Technology and Science Incorporation, Beijing Chenyimeng Technology Co., Ltd., China Technology Industry Group Limited, Hefei Tashi, Hefei Xiangpeng Technology Service Partnership (Limited Partnership)